» Articles » PMID: 26634068

Possible Therapeutic Effect of Stem Cell in Atherosclerosis in Albino Rats. A Histological and Immunohistochemical Study

Overview
Date 2015 Dec 4
PMID 26634068
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Atherosclerosis is the leading cause of death worldwide. there are no effective approaches to regressing atherosclerosis due to not fully understood mechanisms. Recently, stem cell-based therapies have held promises to various diseases, including vascular diseases.

Aim: The present study aimed at investigating the possible effect of cord blood mesenchymal stem cell (MSC) therapy on atherosclerosis.

Material And Methods: Eighty adult male albino rats were divided into control group (I), atherogenic group (II): subjected to high cholesterol fed diet (200~300 mg/kg body weight) for 12 weeks and 1.8 million units of vitamin D / kg of diet for 6 weeks. Stem cell therapy group (III): injected with stem cells in the tail vein following confirmation of atherosclerosis. Histological, Immunohistochemical and morphometric studies were performed were conducted.

Results: Atherogenic group (II) showed increased aortic thickness, intimal proliferation, smooth muscle proliferation and migration. Increased area % of collagen fibers, iNOS and vimentin immunoreactions were recorded and proved morphometrically. All findings regressed on stem cell therapy.

Conclusion: A definite therapeutic effect of mesenchymal stem cells was found on atherosclerosis.

Citing Articles

Nitric Oxide-Releasing Platforms for Treating Cardiovascular Disease.

He M, Wang D, Xu Y, Jiang F, Zheng J, Feng Y Pharmaceutics. 2022; 14(7).

PMID: 35890241 PMC: 9317153. DOI: 10.3390/pharmaceutics14071345.


Delivery of Nitric Oxide in the Cardiovascular System: Implications for Clinical Diagnosis and Therapy.

Ma T, Zhang Z, Chen Y, Su H, Deng X, Liu X Int J Mol Sci. 2021; 22(22).

PMID: 34830052 PMC: 8625126. DOI: 10.3390/ijms222212166.


Therapeutic potential of human umbilical cord mesenchymal stem cells on aortic atherosclerotic plaque in a high-fat diet rabbit model.

Li Y, Shi G, Han Y, Shang H, Li H, Liang W Stem Cell Res Ther. 2021; 12(1):407.

PMID: 34266502 PMC: 8281645. DOI: 10.1186/s13287-021-02490-8.


Human umbilical cord mesenchymal stem cells polarize RAW264.7 macrophages to an anti-inflammatory subpopulation.

Xu Y, Luo H, Chen F, Shi Y, Sun M Int J Clin Exp Pathol. 2020; 11(3):1446-1452.

PMID: 31938242 PMC: 6958167.


The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu.

Mahdavi Gorabi A, Banach M, Reiner Z, Pirro M, Hajighasemi S, Johnston T J Clin Med. 2019; 8(9).

PMID: 31500373 PMC: 6780166. DOI: 10.3390/jcm8091413.


References
1.
Ji F, Wang Y, Sun H, Du J, Zhao H, Wang D . Human umbilical cord blood-derived non-hematopoietic stem cells suppress lymphocyte proliferation and CD4, CD8 expression. J Neuroimmunol. 2008; 197(2):99-109. DOI: 10.1016/j.jneuroim.2008.04.013. View

2.
de Boer H, Verseyden C, Ulfman L, Zwaginga J, Bot I, Biessen E . Fibrin and activated platelets cooperatively guide stem cells to a vascular injury and promote differentiation towards an endothelial cell phenotype. Arterioscler Thromb Vasc Biol. 2006; 26(7):1653-9. DOI: 10.1161/01.ATV.0000222982.55731.f1. View

3.
Gocmen A, Ocak G, Ozbilim G, Delibas N, Gumuslu S . Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats. Can J Physiol Pharmacol. 2013; 91(9):680-5. DOI: 10.1139/cjpp-2012-0325. View

4.
Emsley R, Dunn G, White I . Mediation and moderation of treatment effects in randomised controlled trials of complex interventions. Stat Methods Med Res. 2009; 19(3):237-70. DOI: 10.1177/0962280209105014. View

5.
Burke A, Farb A, Malcom G, Liang Y, Smialek J, Virmani R . Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997; 336(18):1276-82. DOI: 10.1056/NEJM199705013361802. View